142 related articles for article (PubMed ID: 1661161)
1. Differentiation of a mouse neuroblastoma variant cell line whose ornithine decarboxylase gene has been amplified.
Chen ZP; Chen KY
Biochim Biophys Acta; 1991 Dec; 1133(1):1-8. PubMed ID: 1661161
[TBL] [Abstract][Full Text] [Related]
2. Changes of ornithine decarboxylase activity and polyamine content upon differentiation of mouse NB-15 neuroblastoma cells.
Chen KY; Presepe V; Parken N; Liu AY
J Cell Physiol; 1982 Mar; 110(3):285-90. PubMed ID: 6282899
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells.
Chen KY; Nau D; Liu AY
Cancer Res; 1983 Jun; 43(6):2812-8. PubMed ID: 6303569
[TBL] [Abstract][Full Text] [Related]
4. Long-term reduction of amplified ornithine decarboxylase sequences in human myeloma cells.
Wahlfors J; Myöhänen S; Korhonen VP; Alhonen L; Jänne J
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):299-303. PubMed ID: 7646459
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
6. Growth regulatory effects of cyclic AMP and polyamine depletion are dissociable in cultured mouse lymphoma cells.
McConlogue LC; Marton LJ; Coffino P
J Cell Biol; 1983 Mar; 96(3):762-7. PubMed ID: 6300139
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
Taylor JL; Turo KA; McCann PP; Grossberg SE
J Biol Regul Homeost Agents; 1988; 2(1):19-24. PubMed ID: 3140600
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
Taylor JL; Turo KA; McCann PP; Grossberg SE
J Biol Regul Homeost Agents; 1988; 2(2):99-104. PubMed ID: 3142219
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
[TBL] [Abstract][Full Text] [Related]
10. Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells.
Kameji T; Hayashi S; Hoshino K; Kakinuma Y; Igarashi K
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):581-6. PubMed ID: 8424799
[TBL] [Abstract][Full Text] [Related]
11. Cadaverine supplementation during a chronic exposure to difluoromethylornithine allows an overexpression, but prevents gene amplification, of ornithine decarboxylase in L1210 mouse leukaemia cells.
Alhonen-Hongisto L; Hirvonen A; Sinervirta R; Jänne J
Biochem J; 1987 Nov; 247(3):651-5. PubMed ID: 3122732
[TBL] [Abstract][Full Text] [Related]
12. Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells.
Yuan Q; Ray RM; Viar MJ; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G130-8. PubMed ID: 11123206
[TBL] [Abstract][Full Text] [Related]
13. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
Oredsson SM; Billgren M; Heby O
Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells.
Meilhoc E; Moutin MJ; Romani BH; Osborne HB
Exp Cell Res; 1986 Jan; 162(1):142-50. PubMed ID: 3079592
[TBL] [Abstract][Full Text] [Related]
15. Polyamines in 1 alpha, 25-dihydroxycholecalciferol-induced differentiation of human promyelocytic leukemia cells, HL-60.
Inaba M; Otani S; Matsui-Yuasa I; Yukioka K; Nishizawa Y; Ishimura E; Morisada S; Yukioka M; Morisawa S; Morii H
Endocrinology; 1986 May; 118(5):1849-55. PubMed ID: 3084209
[TBL] [Abstract][Full Text] [Related]
16. Polyamine metabolism in Pneumocystis carinii.
Lipschik GY; Masur H; Kovacs JA
J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
[TBL] [Abstract][Full Text] [Related]
17. Polyamine-mediated turnover of ornithine decarboxylase in Chinese-hamster ovary cells.
Glass JR; Gerner EW
Biochem J; 1986 Jun; 236(2):351-7. PubMed ID: 3092809
[TBL] [Abstract][Full Text] [Related]
18. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
19. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
